In order to explore the clinical significance of MUC1 in ICC, all 214 ICC patients were divided into MUC1 low (score negative or weak, n = 87) and MUC1 high (score moderate or strong, n = 127) groups based on immunohistochemical data. This evidence concerns the gene MUC1 and intrahepatic cholangiocarcinoma.